The Synthesis Company of San Francisco Mountain Logo
Sequence Analyses of Relapsed or Refractory Diffuse Large B-Cell Lymphomas Unravels Three Genetic Subgroups of Patients and <i>GNA3</i> Mutant as Poor Prognosis Biomarker, Results of LNH-EP1 Study | doi.page